These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28176769)

  • 1. Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging.
    Cuccarese MF; Dubach JM; Pfirschke C; Engblom C; Garris C; Miller MA; Pittet MJ; Weissleder R
    Nat Commun; 2017 Feb; 8():14293. PubMed ID: 28176769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment.
    Van Overmeire E; Stijlemans B; Heymann F; Keirsse J; Morias Y; Elkrim Y; Brys L; Abels C; Lahmar Q; Ergen C; Vereecke L; Tacke F; De Baetselier P; Van Ginderachter JA; Laoui D
    Cancer Res; 2016 Jan; 76(1):35-42. PubMed ID: 26573801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
    Ao JY; Zhu XD; Chai ZT; Cai H; Zhang YY; Zhang KZ; Kong LQ; Zhang N; Ye BG; Ma DN; Sun HC
    Mol Cancer Ther; 2017 Aug; 16(8):1544-1554. PubMed ID: 28572167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using macrophage activation to augment immunotherapy of established tumours.
    Fridlender ZG; Jassar A; Mishalian I; Wang LC; Kapoor V; Cheng G; Sun J; Singhal S; Levy L; Albelda SM
    Br J Cancer; 2013 Apr; 108(6):1288-97. PubMed ID: 23481183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local Targeting of Lung-Tumor-Associated Macrophages with Pulmonary Delivery of a CSF-1R Inhibitor for the Treatment of Breast Cancer Lung Metastases.
    Alhudaithi SS; Almuqbil RM; Zhang H; Bielski ER; Du W; Sunbul FS; Bos PD; da Rocha SRP
    Mol Pharm; 2020 Dec; 17(12):4691-4703. PubMed ID: 33170724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
    Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
    Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1.
    Shih CT; Shiau CW; Chen YL; Chen LJ; Chao TI; Wang CY; Huang CY; Hung MH; Chen KF
    Cancer Lett; 2021 Feb; 498():142-151. PubMed ID: 33232786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using
    Kim HY; Li R; Ng TSC; Courties G; Rodell CB; Prytyskach M; Kohler RH; Pittet MJ; Nahrendorf M; Weissleder R; Miller MA
    ACS Nano; 2018 Dec; 12(12):12015-12029. PubMed ID: 30508377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
    Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
    J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages mediated delivery of chlorin e6 and treatment of lung cancer by photodynamic reprogramming.
    Yu TT; Sang XY; Han N; Peng XC; Li QR; Xu X; Xiao RC; Xu HZ; Chen X; Wang MF; Li TF
    Int Immunopharmacol; 2021 Nov; 100():108164. PubMed ID: 34562845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-148b-colony-stimulating factor-1 signaling-induced tumor-associated macrophage infiltration promotes hepatocellular carcinoma metastasis.
    Ke M; Zhang Z; Cong L; Zhao S; Li Y; Wang X; Lv Y; Zhu Y; Dong J
    Biomed Pharmacother; 2019 Dec; 120():109523. PubMed ID: 31655310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.
    Murga-Zamalloa C; Rolland DCM; Polk A; Wolfe A; Dewar H; Chowdhury P; Onder O; Dewar R; Brown NA; Bailey NG; Inamdar K; Lim MS; Elenitoba-Johnson KSJ; Wilcox RA
    Clin Cancer Res; 2020 Feb; 26(3):690-703. PubMed ID: 31636099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water extract of ginseng and astragalus regulates macrophage polarization and synergistically enhances DDP's anticancer effect.
    Chen Y; Bi L; Luo H; Jiang Y; Chen F; Wang Y; Wei G; Chen W
    J Ethnopharmacol; 2019 Mar; 232():11-20. PubMed ID: 30529424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging endogenous macrophage iron deposits reveals a metabolic biomarker of polarized tumor macrophage infiltration and response to CSF1R breast cancer immunotherapy.
    Leftin A; Ben-Chetrit N; Joyce JA; Koutcher JA
    Sci Rep; 2019 Jan; 9(1):857. PubMed ID: 30696910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin.
    Pass HI; Lavilla C; Canino C; Goparaju C; Preiss J; Noreen S; Blandino G; Cioce M
    Oncotarget; 2016 Aug; 7(35):56408-56421. PubMed ID: 27486763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer.
    Kulkarni A; Chandrasekar V; Natarajan SK; Ramesh A; Pandey P; Nirgud J; Bhatnagar H; Ashok D; Ajay AK; Sengupta S
    Nat Biomed Eng; 2018 Aug; 2(8):589-599. PubMed ID: 30956894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the herbal medicine triggering innate anti-tumor immunity from a system pharmacology perspective.
    Xiao Y; Zhang L; Zhu J; Zhang Y; Yang R; Yan J; Huang R; Zheng C; Xiao W; Huang C; Wang Y
    Biomed Pharmacother; 2021 Nov; 143():112105. PubMed ID: 34560533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.
    DeNardo DG; Brennan DJ; Rexhepaj E; Ruffell B; Shiao SL; Madden SF; Gallagher WM; Wadhwani N; Keil SD; Junaid SA; Rugo HS; Hwang ES; Jirström K; West BL; Coussens LM
    Cancer Discov; 2011 Jun; 1(1):54-67. PubMed ID: 22039576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.
    Guerriero JL; Sotayo A; Ponichtera HE; Castrillon JA; Pourzia AL; Schad S; Johnson SF; Carrasco RD; Lazo S; Bronson RT; Davis SP; Lobera M; Nolan MA; Letai A
    Nature; 2017 Mar; 543(7645):428-432. PubMed ID: 28273064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.